Extbase Variable Dump
'2023-10-20 03:52:00' (19 chars)
Extbase Variable Dump
array(38 items)
   specificEvent => array(46 items)
      uid => 2 (integer)
      pid => 27 (integer)
      tstamp => 1682586345 (integer)
      crdate => 1588073967 (integer)
      cruser_id => 4 (integer)
      deleted => 0 (integer)
      hidden => 0 (integer)
      starttime => 0 (integer)
      endtime => 0 (integer)
      t3ver_oid => 0 (integer)
      t3ver_id => 0 (integer)
      t3ver_wsid => 0 (integer)
      t3ver_label => '' (0 chars)
      t3ver_state => 0 (integer)
      t3ver_stage => 0 (integer)
      t3ver_count => 0 (integer)
      t3ver_tstamp => 0 (integer)
      t3ver_move_id => 0 (integer)
      sys_language_uid => 0 (integer)
      l10n_parent => 0 (integer)
      l10n_diffsource => '{"sys_language_uid":"","hidden":"","title":"","start_date":"","end_time":"",
         "multiple_date":"","start_time":"","end_date":"","teaser":"","description":"
         ","link":"","repeat_event":"","location":"","organisator":"","latitude":"","
         longitude":"","related_events":"","image":"","youtube_code":"","color_picker
         ":"","predefined_color":"","location_image":"","detail_page":"","slug":"","c
         ancelevent":"","starttime":"","endtime":""}
' (423 chars) l10n_state => NULL title => 'KI in der Pankreas-Diagnostik' (29 chars) start_date => '2023-01-20 03:01:00' (19 chars) end_time => '04:59:00' (8 chars) multiple_date => 0 (integer) start_time => '03:52:00' (8 chars) end_date => '2023-10-20 03:52:00' (19 chars) teaser => '<p>Früherkennung verbessert Überlebens-Chancen - Künstliche Intelligenz s
         oll die Diagnostik revolutionieren</p>
' (114 chars) description => '<p>Erkrankungen des Pankreas können für Patienten gravierende Folgen haben
          und sind schwierig zu diagnostizieren. Eine Früherkennung ist für die Üb
         erlebenschance der Patienten entscheidend. In Europa sterben heute mehr als
         90 Prozent der Patienten innerhalb der ersten fünf Jahre nach der Diagnose
         an Pankreas-Krebs. Die Medi-Globe Group, ein international führendes Medizi
         ntechnik-Unternehmen mit Sitz im bayerischen Achenmühle, wird in Zusammenar
         beit mit dem französischen Institut Hospitalo-Universitaire (IHU) Straßbur
         g die weltweit erste KI-Software zur Erkennung von Erkrankungen der Bauchspe
         icheldrüse bei endoskopischen Ultraschall-Untersuchungen (EUS) entwickeln.
         Schlüsseltechnologie ist dabei die Künstliche Intelligenz. Im Rahmen der g
         roß angelegten klinischen Studien auf dem Weg zur Marktreife konnte nun die
          KI-Software in die Erprobung am Patienten, die sogenannte First-in-human-An
         wendung, gehen.</p> <p>"Die neue Software hat das Potential, die Diagnostik
          von Pankreas-Erkrankungen und vor allem auch die Diagnostik von Bauchspeich
         eldrüsen-Krebs zu revolutionieren. Das wäre ein Traum für die ganze Gesel
         lschaft und ein wichtiger Meilenstein in der Medizin und in der Medizintechn
         ik", freut sich Prof. Dr. Leonardo Sosa Valencia, einer der führenden Gastr
         oenterologen weltweit und Top-Experte im Bereich der Erkennung von Erkrankun
         gen der Bauchspeicheldrüse.</p> <p>"Mit der KI-Software werden wir zukünf
         tig den gastroenterologischen Fachärzten einen virtuellen Experten zur Seit
         e stellen können und ihnen die Möglichkeit geben, die Therapie bestimmende
          Diagnostik wesentlich zu verbessern. Bei den klinischen Erstanwendungen kon
         nten bereits sehr gute Ergebnisse erzielt werden. Kleine Läsionen wurden de
         tektiert, auch bei komplexen Fällen. Das gibt den behandelnden Ärzten und
         vor allem betroffenen Patienten große Hoffnung und wird mittelfristig die P
         atientenversorgung nachhaltig verbessern", so Dr. Markus Schönberger, Direc
         tor Business Development...
' (3983 chars) repeat_event => 'daily' (5 chars) link => '' (0 chars) location => 'Weltweit' (8 chars) organisator => 'internationaler Kalender' (24 chars) related_events => '' (0 chars) image_path => '' (0 chars) image => 1 (integer) youtube_code => '' (0 chars) latitude => '49.403449' (9 chars) longitude => '8.684193' (8 chars) color_picker => '' (0 chars) predefined_color => '' (0 chars) location_image => 0 (integer) detail_page => '' (0 chars) slug => 'ki-in-der-pankreas-diagnostik' (29 chars) cancelevent => 1 (integer)
title => 'AI in pancreas diagnostics' (26 chars) description => '<p>Diseases of the pancreas can have serious consequences for patients and a
      re difficult to diagnose. Early detection is crucial for patients' chance of
       survival. In Europe today, more than 90 per cent of patients die from pancr
      eatic cancer within the first five years after diagnosis. The Medi-Globe Gro
      up, a leading international medical technology company based in Achenmühle,
       Bavaria, will collaborate with the French Institut Hospitalo-Universitaire
      (IHU) Strasbourg to develop the world's first AI software to detect pancreat
      ic disease during endoscopic ultrasound (EUS) examinations. The key technolo
      gy here is artificial intelligence. As part of the large-scale clinical tria
      ls on the way to market maturity, the AI software could now go into testing
      on patients, the so-called first-in-human application.</p> <p>"The new soft
      ware has the potential to revolutionise the diagnosis of pancreatic diseases
       and especially the diagnosis of pancreatic cancer. This would be a dream co
      me true for the whole society and an important milestone in medicine and med
      ical technology," enthuses Prof. Dr. Leonardo Sosa Valencia, one of the worl
      d's leading gastroenterologists and a top expert in the field of pancreatic
      disease detection.</p> <p>"With the AI software, we will be able to provide
       gastroenterological specialists with a virtual expert in the future and giv
      e them the opportunity to significantly improve the diagnostics that determi
      ne therapy. Very good results have already been achieved in the initial clin
      ical applications. Small lesions have been detected, even in complex cases.
      This gives great hope to the treating physicians and, above all, affected pa
      tients and will sustainably improve patient care in the medium term," says D
      r Markus Schönberger, Director Business Development at the Medi-Globe Group
      .</p> <p><strong>Deep Learning: Clinical experience of world-leading gastro
      enterologists</strong></p> <p>The AI software brings together the clinical
      experience of the world'...
' (3728 chars) teaser => '<p>Early detection improves chances of survival - Artificial intelligence to
       revolutionise diagnostics</p>
' (106 chars) location => 'Worldwide' (9 chars) image => TYPO3\CMS\Extbase\Domain\Model\FileReferenceprototypepersistent entity (uid=4154, pid=27) uidLocal => protected1099 (integer) originalResource => protectedNULL uid => protected4154 (integer) _localizedUid => protected5259 (integer)modified _languageUid => protected1 (integer)modified _versionedUid => protected4154 (integer)modified pid => protected27 (integer) month => ' Jan ' (5 chars) year => ' 2023 ' (6 chars) startTime => '03:01' (5 chars) endTime => '03:52' (5 chars) startDay => ' 20 ' (4 chars) startDayName => 'Friday' (6 chars) endDay => ' 20 ' (4 chars) endMonth => ' Oct ' (5 chars) endYear => ' 2023 ' (6 chars) google_map_api => '' (0 chars) google_map_zoom => '7' (1 chars) google_map_style => '' (0 chars) hideDate => '' (0 chars) youTube => '' (0 chars) link => '' (0 chars) latitude => '49.403449' (9 chars) longitude => '8.684193' (8 chars) organisator => 'international calendar' (22 chars) targetDay => 20 (integer) targetMonth => 10 (integer) targetYear => 2023 (integer) targetHour => 3 (integer) targetMinute => 52 (integer) targetSecond => 0 (integer) relatedEvents => array(empty) multipleDateTimeArray => array(empty) getStart => '20.01.2023' (10 chars) startDateFinishTime => '04:59' (5 chars) getEnd => '20.10.2023' (10 chars) endDatelaunchTime => '03:52' (5 chars) locationImage => NULL cancelevent => 1 (integer)
Events

AI in pancreas diagnostics

Early detection improves chances of survival - Artificial intelligence to revolutionise diagnostics

Diseases of the pancreas can have serious consequences for patients and are difficult to diagnose. Early detection is crucial for patients' chance of survival. In Europe today, more than 90 per cent of patients die from pancreatic cancer within the first five years after diagnosis. The Medi-Globe Group, a leading international medical technology company based in Achenmühle, Bavaria, will collaborate with the French Institut Hospitalo-Universitaire (IHU) Strasbourg to develop the world's first AI software to detect pancreatic disease during endoscopic ultrasound (EUS) examinations. The key technology here is artificial intelligence. As part of the large-scale clinical trials on the way to market maturity, the AI software could now go into testing on patients, the so-called first-in-human application.

"The new software has the potential to revolutionise the diagnosis of pancreatic diseases and especially the diagnosis of pancreatic cancer. This would be a dream come true for the whole society and an important milestone in medicine and medical technology," enthuses Prof. Dr. Leonardo Sosa Valencia, one of the world's leading gastroenterologists and a top expert in the field of pancreatic disease detection.

"With the AI software, we will be able to provide gastroenterological specialists with a virtual expert in the future and give them the opportunity to significantly improve the diagnostics that determine therapy. Very good results have already been achieved in the initial clinical applications. Small lesions have been detected, even in complex cases. This gives great hope to the treating physicians and, above all, affected patients and will sustainably improve patient care in the medium term," says Dr Markus Schönberger, Director Business Development at the Medi-Globe Group.

Deep Learning: Clinical experience of world-leading gastroenterologists

The AI software brings together the clinical experience of the world's most experienced gastroenterologists. It bundles the knowledge from countless EUS examinations of the pancreas into an algorithm and transforms it into an application for endoscopic ultrasound examinations. In the process, the expert knowledge is used to train a neural network according to the Deep Learning method. The innovative diagnostic software created according to this method is intended to find details during the examination of the pancreas that often remain hidden from the doctor's view. For diagnosis, it is crucial to detect pathologically altered areas in the pancreas at an early stage so that tissue samples can then be taken with pinpoint accuracy, e.g. by means of a fine-needle biopsy, the evaluation of which is decisive for the decision on therapy.

"The interpretation of EUS images is demanding, strongly dependent on the user and requires several years of training and specialisation. The partnership with Medi-Globe Group aims to demonstrate the utility of modern AI approaches in the analysis of these complex images and to support gastroenterologists to detect pancreatic cancer more effectively," explains Prof. Dr. Nicolas Padoy, Director of AI Research at IHU Strasbourg.

"We cooperate very closely with leading international university hospitals. With the help of artificial intelligence, together with the researchers at IHU, we will be able to make the clinical experience knowledge of world-leading gastroenterologists available to all doctors in the future. We are thus consistently expanding our role as an innovation leader in minimally invasive diagnostics and therapy," says Marc Jablonowski, Chief Technology & Innovation Officer (CTIO) at the Medi-Globe Group.

Organisator: international calendar

logo